Health Care Costs

Latest KFF Health News Stories

Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?

KFF Health News Original

Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.

Watch: The Politics of Health Care in California

KFF Health News Original

KHN senior correspondent Angela Hart discussed the most pressing health care issues in California with the nonpartisan group Democracy Winters in mid-November, touching on a variety of issues, from the state’s effort to transform its Medicaid program to its plan to produce generic insulin.

KHN’s ‘What the Health?’: The Changing of the Guard

KFF Health News Original

Democrats retained control of the U.S. Senate in the midterm elections, while Republicans won a majority in the House, giving them the ability to block items on President Joe Biden’s agenda. Meanwhile, the lame-duck, Democratic-led Congress won’t have the votes to pass abortion rights legislation, although they may try to undo some long-standing anti-abortion policies in federal spending bills. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Victoria Knight of Axios, and Alice Miranda Ollstein of Politico, join KHN’s Julie Rovner to discuss these topics and more.

How Optimism Can Close the Medicaid Coverage Gap

KFF Health News Original

Low-income residents in states that haven’t expanded Medicaid are in a tough spot: They don’t qualify for the subsidies that people with slightly higher incomes get to buy marketplace plans because of a glitch in the federal health law. But a court decision last year makes it easier for them to make good-faith estimates of a pay increase, and there is no financial penalty if they don’t hit that figure.

Medicare Plan Finder Likely Won’t Note New $35 Cap on Out-of-Pocket Insulin Costs

KFF Health News Original

In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.